LABORATORIOS FARMACEUTICOS ROVI, S.A. «...678910...» Page 10 out of 19 30/06/2022 08:10 LABORATORIOS FARMACEUTICOS ROVI, S.A. Other relevant information The Company informs about the dividends payment Register number: 17128 16/06/2022 08:00 LABORATORIOS FARMACEUTICOS ROVI, S.A. Other relevant information The Company has agreed to execute the capital reduction approved by the 2022 Ordinary General Meeting to amortize the shares acquired in the framework of the own shares repurchase programs. Register number: 16848 Related to communication no. 16801 dated 14/06/2022 (15:02) 14/06/2022 15:02 LABORATORIOS FARMACEUTICOS ROVI, S.A. Announcement of general shareholders’ meeting La Sociedad informa sobre la celebración de su Junta General Ordinaria de Accionistas. Register number: 16801 11/05/2022 07:44 LABORATORIOS FARMACEUTICOS ROVI, S.A. On corporate governance La Sociedad informa sobre el nombramiento de un nuevo miembro en su Consejo de Administración. Register number: 16218 11/05/2022 07:39 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases the presentation related to the first quarter 2022 financial results Register number: 16217 11/05/2022 07:38 LABORATORIOS FARMACEUTICOS ROVI, S.A. Announcement of general shareholders’ meeting La Sociedad informa sobre el acuerdo de convocatoria de su Junta General Ordinaria de Accionistas 2022. Register number: 16216 11/05/2022 07:37 LABORATORIOS FARMACEUTICOS ROVI, S.A. On business and financial situation The Company releases the press release related to the first quarter 2022 financial results Register number: 16215 05/04/2022 14:13 LABORATORIOS FARMACEUTICOS ROVI, S.A. Liquidity and counterparty agreements ROVI communicates that it has entered into a liquidity agreement with Bestinver S.V., S.A. Register number: 15427 29/03/2022 09:47 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted on 28 March 2022 and end of the share buyback program Register number: 15206 28/03/2022 11:15 LABORATORIOS FARMACEUTICOS ROVI, S.A. Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 21 March 2022 and 25 March 2022 Register number: 15188 Page 10 out of 19 «...678910...»
